Phase I/II study of gemtuzumab ozogamicin added to fludarabine, melphalan and allogeneic hematopoietic stem cell transplantation for high-risk CD33 positive myeloid leukemias and myelodysplastic syndrome (Q46909610)
Jump to navigation
Jump to search
scientific article published on 8 November 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I/II study of gemtuzumab ozogamicin added to fludarabine, melphalan and allogeneic hematopoietic stem cell transplantation for high-risk CD33 positive myeloid leukemias and myelodysplastic syndrome |
scientific article published on 8 November 2007 |
Statements
1 reference
Phase I/II study of gemtuzumab ozogamicin added to fludarabine, melphalan and allogeneic hematopoietic stem cell transplantation for high-risk CD33 positive myeloid leukemias and myelodysplastic syndrome (English)
1 reference
1 reference
E J Shpall
1 reference
R E Champlin
1 reference
S Giralt
1 reference
I Khouri
1 reference
M de Lima
1 reference
P F Thall
1 reference
X Wang
1 reference
T G Martin
1 reference
J D Cook
1 reference
G McCormick
1 reference
M Qazilbash
1 reference
P Kebriaei
1 reference
D Couriel
1 reference
P Anderlini
1 reference
K W Chan
1 reference
B S Andersson
1 reference
P A Patah
1 reference
Z Caldera
1 reference
E Jabbour
1 reference
8 November 2007
1 reference
1 reference
22
1 reference
258-264
1 reference
2
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference